OTC · Medical - Pharmaceuticals

The Greater Cannabis Company, Inc. (GCAN) Stock

$0.28 -16.39% OTC: GCAN Healthcare

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics.

Valuation

MetricValue
Price$0.28
Market Cap$278425
P/E Ratio2800.00
P/B Ratio-341.38
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.67
52-Week Low$0.04
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE13.26%
ROA-453.40%
ROCE22.30%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.35
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$-1.0M$-1.0M$0$0$0
EPS$0.00$0.00$0.00$0.00$-0.40
Op Margin-2716.9%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$0
Total Liabilities$1.0M$1.0M$1.0M$1.0M$1.0M
Cash$0$0$0$0$0
Borrowings$1.0M$1.0M$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.42
EV / EBITDA-2.09
FCF Yield-19.17%
Quick Ratio0.00
Interest Coverage403.84
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held53.10%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADVTAdvantis Corp. $0.00 — -0.41 $9785 0.00%
BBBTBlack Bird Biotech, Inc. $0.00 — -0.02 $98405 0.00%
CANLCannLabs, Inc. $0.00 — 0.09 $93317 0.00%
EAPHParallel Industries Inc. $0.00 — -0.20 $26899 0.00%
GREHGreen Rain Energy Holdings Inc. $0.01 +0.00% 0.28 $109851 0.00%

About The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.

The Greater Cannabis Company, Inc. is headquartered in US.

The Greater Cannabis Company, Inc. (GCAN) stock trades at $0.28 with a market capitalization of $278425. The stock is valued at a price-to-earnings (P/E) ratio of 2800.00, price-to-book of -341.38, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.04 and $0.67, and currently trades 58.2% below its 52-week high.

On profitability, The Greater Cannabis Company, Inc. generates a return on equity (ROE) of 13.26%, above the typical market average, return on capital employed of 22.30%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.gcanrx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides